The Heartbeat Trust


November 2014:

Heartbeat Trust Researcher wins inaugural Brian Maurer Young Investigator of the Year Award 

The Heartbeat Trust is delighted to announce that Dr Chris Watson, a Senior Researcher with the Heartbeat Trust and the Conway Institute at UCD, was awarded the Brian Maurer Young Investigator Award at the recent Irish Cardiac Society Annual Scientific Meeting held in Athlone.

Dr Watson received the award for his work Epigenetic Modifying Therapy for the Treatment of Cardiac Fibrosis and Hypertrophy. This work formed the basis of Dr Watson’s recent funding award from Enterprise Ireland, which entails building a commercial case for epigenetic modifying therapy for the treatment of cardiomyopathies.

The Irish Cardiac Society annual Young Investigator Award was renamed this year as the Brian Maurer Young Investigator Award in honour of Dr Brian Maurer, former Chairman of the Heartbeat Trust, who passed away in 2013. For more details click here

New Virtual Consultation Service

The Heartbeat Trust in association with Cardiomark is providing a new virtual consultation service, designed to help guide registered users about patients with suspected heart failure. If you are a registered user, click on the link below to schedule a virtual consultation. If you are not a registered user, please Contact Us to find out more. 

Click here to schedule a virtual consultation 

October 2014:

STOP-HF research study wins prestigious award

The Heartbeat Trust is delighted to announce that the STOP-HF research study has been given a prestigious international research award by the Royal College of General Practitioners. Click here for more.

April 2014:

STOP-HF public meeting on cardiovascular disease in diabetes in association with the Health Research Board and the European Commission Framework Programme 7

A video summary of the second STOP-HF public meeting on cardiovascular disease has been released. The meeting was attended by over 300 people associated with the STOP-HF follow on programme with a focus on diabetes.

Hosted by the Heartbeat Trust, speakers include Professor Donal O'Shea, Consultant Endocrinologist as well as Professor Ken McDonald and Dr Joe Gallagher from the STOP-HF programme. View highlights in the YouTube clip.

For a recording of the post talk discussion, click here.  

Jan 2014

Evidence Based Medicine provides a commentary on the STOP-HF programme 

The BMJ's Evidence-Based Medicine systematically searches a wide range of international medical journals applying strict criteria for the validity of research. Recently, experts critically appraised the STOP-HF study, supported by the Heartbeat Trust.  To read the report, click here

September 2013

The recent Heartbeat Trust public meeting on STOP-HF for the programme participants 

More than 300 participants met with the Trust and the study team in Dun Laoghaire, Co Dublin, in the first of a series of public meetings to discuss the results and the future of the programme.

The team was joined by Minister Alex White TD, Minister of State at the Department of Health with responsibility for Primary Care. Minister White who told the audience about the importance of STOP-HF and the need to strengthen primary care.

Speakers were Professor Ken McDonald and Dr Joe Gallagher from the STOP-HF programme. View a brief clip with highlights in the YouTube clip


October 2013

Prevention of Heart Failure biomarker driven prevention of heart failure. The PONTIAC trial is published in the Journal of the American College of Cardiology this October.

The PONTIAC study follows on from the larger STOP-HF study focusing on patients with diabetes. This study sought to assess the primary preventive effect of cardioprotective therapy in high-risk patients with diabetes selected by N-terminal pro–B-type natriuretic peptide (NT-proBNP). After 12 months there was a significant difference between the number of patients treated with cardioprotective therapies. Also, this was an effective and safe intervention for the primary prevention of cardiac events for diabetic patients pre-selected using NT-proBNP. 

The PONTIAC study, along with the STOP-HF study, provides important evidence that prevention of heart failure is an attainable goal. View a commentary in the YouTube clip.

The Heartbeat Trust is all about preventing heart disease

The Heartbeat Trust is helping to lead the way in prevention of heart disease

             STOP-HF Programme       St Vincents CCDU              Our Research              Join our email list          What is heart failure?

The Heartbeat Trust is a registered charity based in Dun Laoghaire, Dublin, Ireland which is dedicated to  the prevention, early detection and treatment of heart failure (where the muscle of the heart does not work as well as it should do).

Located in the east coast area of Ireland, the Trust has a network of collaborators and stakeholders giving national and international impact.

The Heartbeat Trust also provides healthcare services and carries out innovative research in conjunction with the St Vincents Chronic Cardiovascular Disease Unit

Our research

To date there have been more than 70 peer reviewed publications from the unit. In addition, unit personnel have made in excess of 150 presentations at national and international meetings. To find out more about our research, click here

Our news

  • March 2013. The STOP-HF study is a major research programme focused on prevention of heart failure -
  • July 2013. The STOP-HF study is published in the Journal of the American Medical Association - see press release
  • July 2013. Adrian Hernandez, MD, Duke University, talks about the implications of the STOP-HF trial in JAMA - see report
  • August 2013. Gary S. Francis, MD, University of Minnesota, talks about Heart Failure with Preserved Ejection Fraction
  • September 2013. Inaugural Heartbeat Trust Annual Public Meeting - the STOP-HF programme and future initiatives. To view a quick video of the evening, click here
  • October 2013. Momentum grows for prevention of heart failure as the PONTIAC trial is published in the Journal of the American College of Cardiology. See commentary here
  • January 2014. Read the BMJ Evidence Based Medicine review of the STOP-HF study here
  • April 2014. Watch highlights of the presentations at the STOP-HF public meeting on diabetes supported by the HRB and FP7 here
  • September 2014. The Heartbeat Trust in association with Cardiomark provides a new virtual consultation service for healthcare professionals, which is designed to help guide referrals for patients with suspected heart failure
  • October 2014. STOP-HF Research Study wins prestigious Royal College of General Practitioners Award. For more information, click here
  • November 2014. STOP-HF Researcher wins inaugural Brian Maurer Young Investigator of the Year Award. Click here for more 

Crofton Cardiac Centre, 3 Crofton Terrace, Dun Laoghaire, Co Dublin, Ireland | +353 1 2304629